Exozymes Inc. (EXOZ) — 10-Q Filings
All 10-Q filings from Exozymes Inc.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (4)
-
EXOZ Net Loss Widens 62% Amid Cash Burn, Going Concern Doubt
— Nov 13, 2025 Risk: high
EXOZYMES INC. (EXOZ) reported a significant increase in net losses and cash used in operations for the nine months ended September 30, 2025. The company's net l -
EXOZ Net Loss Widens 78% Amid Soaring R&D, G&A Costs
— Aug 12, 2025 Risk: high
EXOZYMES INC. (EXOZ) reported a significant increase in net losses for the six months ended June 30, 2025, reaching $4,216,707, up from $2,368,988 in the prior -
ExoZymes Inc. Files Q1 2025 10-Q
— May 12, 2025 Risk: medium
ExoZymes Inc. filed its 10-Q for the period ending March 31, 2025, reporting on its financial performance. The company, formerly known as Invizyne Technologies -
Invizyne Technologies Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Invizyne Technologies Inc. filed its 10-Q for the period ending September 30, 2024. The company, incorporated in Nevada and operating in the biological products
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX